Page 187 - Aet News Today

GSK gave Vir Biotechnology a Valentine’s Day break-up message, but it’s not a complete goodbye. Though the two companies are ending their Covid-19 collaboration, they’ll still work together on other respiratory programs, including a prophylactic influenza antibody drug that is in mid-stage clinical development.

By continually seeking ways to ease the financial strain of care, hospitals and health systems can position themselves as a trusted advisor for the communities they serve. It’s an approach that is vital to maintaining relationships and revenue.

Instead of pushing data out into the world, it’s possible to invite selected partners into trusted data environments where they can safely harness your data — without ever directly viewing your datasets. Though not designed for clinical care functions, having records safely sequestered in a trusted data environment can help organizations to restore compromised data systems more rapidly.

The deficiency of nurse-specific billing data makes nurses literally and figuratively invisible in terms of political and financial decision-making capacity within the U.S. healthcare sector.

Frequency Therapeutics said its hearing loss drug candidate failed to beat a placebo in its second mid-stage clinical trial. The biotech is now focusing its regenerative medicine platform on the development of a multiple sclerosis drug not expected to reach the clinic until next year.

Tilt Biotherapeutics, Evonetix, and Garuda Therapeutics are among the biotech startups that raised money in the past week.

The Health Affairs study found that in 2006, 10.7% of primary care visits addressed mental health concerns, compared 15.9% by 2016 and 2018, representing a 50% increase.

Here is a selection of recent executive hires, departures and layoffs occurring across the healthcare industry.

New York City-based eFamilyCare offers an app that caregivers can use to connect with care advisers via chat or video. This adviser can provide coaching, help caregivers find services and collaborate with providers. The expanded partnership comes after the two organizations launched a pilot program in 2022.

Behavioral health will continue to take center stage in 2023. It is critical that industry stakeholders collaborate to identify critical mental health needs and leverage available technology to produce meaningful change.